InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.8078
-0.0248 (-2.98%)
At close: Jun 27, 2025, 4:00 PM
0.7812
-0.0266 (-3.29%)
After-hours: Jun 27, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Monoclonal Antibodies
68.21K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
68.21K